| 000 | 01888 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513081213.0 | ||
| 264 | 0 | _c19930430 | |
| 008 | 199304s 0 0 eng d | ||
| 022 | _a0937-941X | ||
| 024 | 7 |
_a10.1007/BF01621911 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGutteridge, D H | |
| 245 | 0 | 0 |
_aFluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies? _h[electronic resource] |
| 260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _c1993 |
||
| 300 |
_a215-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Resorption _xprevention & control |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorides _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aSodium Fluoride _xtherapeutic use |
| 650 | 0 | 4 | _aTablets, Enteric-Coated |
| 700 | 1 | _aKent, G N | |
| 700 | 1 | _aPrince, R L | |
| 700 | 1 | _aNicholson, G C | |
| 700 | 1 | _aStewart, G O | |
| 700 | 1 | _aJones, C E | |
| 700 | 1 | _aBhagat, C I | |
| 700 | 1 | _aStuckey, B G | |
| 700 | 1 | _aRetallack, R W | |
| 773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 3 Suppl 1 _gp. 215-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01621911 _zAvailable from publisher's website |
| 999 |
_c8460836 _d8460836 |
||